Intercellular adhesion molecule-1 expression in adjuvant arthritis in rats: Inhibition by κ-opioid agonist but not by NSAID

Journal of Rheumatology

Volumn 25, Issue 3, 1998, Pages 499-505

  Wilson, Jodie L ^a   Walker, Judith S ^a   Antoon, Juliette S ^a   Perry, Michael A ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Adjuvant arthritis; ICAM 1; NSAID; Opioids

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; KAPPA OPIATE RECEPTOR AGONIST; N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZO[B]THIOPHENE 4 ACETAMIDE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADJUVANT ARTHRITIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; POLYARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, EXPERIMENTAL; FEMALE; INTERCELLULAR ADHESION MOLECULE-1; NAPROXEN; NARCOTICS; PYRROLES; RATS; RATS, INBRED LEW; RECEPTORS, OPIOID, KAPPA; THIOPHENES;

EID: 0031909671     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Koch AE, Burrows JC, Haines GK, Carlos TM, Harlan JM, Leibovich SJ. Immunolocalization of endothelial and leukocyte adhesion molecules in human rheumatoid and osteoarthritic synovial tissues. Lab Invest 1991;64:313-20.
2. Mikecz K, Brennan FR, Kim JH, Giant TT. The role of adhesion molecules in the development of autoimmune arthritis. Scand J Rheumatol 1995;24:99-106.
3. Ohh M, Takei F. New insights into the regulation of ICAM-1 gene expression. Leuk Lymphoma 1995;20:223-8.
4. Szekanecz Z, Haines GK, Lin TR, et al. Differential distribution of intercellular adhesion molecules (ICAM-1, ICAM-2 and ICAM-3) and the MS-1 antigen in normal and diseased human synovia. Their possible pathogenetic and clinical significance in rheumatoid arthritis. Arthritis Rheum 1994;37:221-31.
5. Iigo Y, Takashi T, Tamatani T, et al. ICAM-1 dependent pathway is critically involved in the pathogenesis of adjuvant arthritis in rats. J Immunol 1991;147:4167-71.
6. Pincus T, Marcum SB, Callahan LF. Longterm drug therapy for rheumatoid arthritis in seven rheumatology private practices. II. Second line drugs and prednisone. J Rheumatol 1992;19:1885-94.
7. Lopker A, Abood LG, Hoss W, Lionetti FJ. Stereoselective muscarinic acetylcholine and opiate receptors in human phagocytic leukocytes. Biochem Pharmacol 1980;29:1361-5.
8. Bryant HU, Holaday JW. Opioids in immunologic processes. In: Herz A, editor. Handbook of experimental pharmacology: opioids II. Berlin: Springer-Verlag, 1993:361-92.
9. Stefano GB. Role of opioid neuropeptides in immunoregulation. Prog Neurobiol 1989;33:149-59.
10. Belkowski SM, Alicea C, Eisenstein TK, Adler MW, Rogers TJ. Inhibition of interleukin-1 and tumor necrosis factor-α synthesis following treatment of macrophages with the kappa opioid agonist U-50,488H. J Pharmacol Exp Ther 1995;273:1491-6.
11. Jaffe JH, Martin WR. Opioid analgesics and antagonists. In: Goodman LS, Gilman A. editors. The pharmacological basis of therapeutics. New York: Macmillan, 1994:485-521.
12. Porreca FH, Mosberg HI, Hurst R, Hruby VJ, Burks TF. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse. J Pharmacol Exp Ther 1984;230:341-8.
13. Wilson JL, Nayanar V, Walker JS. The site of anti-arthritic action of the κ-opioid, U-50,488H, in adjuvant arthritis: importance of local administration. Br J Pharmacol 1996;118:1754-60.
14. Clark CR, Birchmore B, Sharif NA, Hunter JC, Hill RG, Hughes J. PD117302: a selective agonist for the κ-opioid receptor. Br J Pharmacol 1988;93:618-26.
15. Colombo M, Petrillo P, La Regina A, Bianchi G, Tavani A. In vitro binding profile and in vivo pharmacological properties of the K-opioid compound PD117302. Res Commun Chem Pathol Pharmacol 1991;72:295-306.
16. Panés J, Perry MA, Anderson DC, et al. Regional differences in constitutive and induced ICAM-1 expression in vivo. Am J Physiol 1995;269:H1955-64.
17. Walker JS, Howlett CR, Nayanar V. Anti-inflammatory effects of kappa-opioids in adjuvant arthritis. Life Sci 1995;57:371-8.
18. Ackerman NR, Rooks WH II, Short L, Genant H, Maloney P, West E. Effects of naproxen on connective tissue changes in the adjuvant arthritic rat. Arthritis Rheum 1979;2:1365-72.
19. McCafferty D-M, Granger DN, Wallace JL. Indomethacin-induced gastric injury and leucocyte adherence in arthritic versus healthy rats. Gastroenterology 1995;109:1173-80.
20. Decker JL, Plotz PH. Extra-articular rheumatoid disease. In: McCarty DJ, editor. Arthritis and allied conditions. Philadelphia: Lea & Febiger, 1985:620-42.
21. Andrews FJ, Malcontenti-Wilson C, O'Brien PE. Effect of non-steroidal anti-inflammatory drugs on LFA-1 and ICAM-1 expression in gastric mucosa. Am J Physiol 1994;266:G657-64.
22. Kasper M, Koslowski R, Luther T, Schuh D, Müller M, Wenzel K-W. Immunohistochemical evidence for loss of ICAM-1 by alveolar epithelial cells in pulmonary fibrosis. Histochem Cell Biol 1995;104:397-405.
23. Rothlein R, Mainolfi EA, Czajkowski M, Barton RW. A form of circulating ICAM-1 in human serum. J Immunol 1991;147:3788-93.
24. Issekutz AC, Meager A, Otterness I, Issekutz TB. The role of tumour necrosis factor-α and IL-1 in polymorphonuclear and T lymphocyte recruitment to joint inflammation in adjuvant arthritis. Clin Exp Immunol 1994;97:26-32.
25. Walker JS. NSAID: an update on their analgesic effects. Clin Exp Pharmacol Physiol 1995;22:855-60.
26. Sipe JD, Bartle LM, Loose LD. Modification of proinflammatory cytokine production by the antirheumatic agents tenidap and naproxen. A possible correlate with clinical acute phase response. J Immunol 1992;148:480-4.
27. Barber A, Bartosyk GD, Bender HM, et al. A pharmacological profile of the novel, peripherally selective κ-opioid receptor agonist, EMD 61753. Br J Pharmacol 1994;113:1317-27.
28. Walker JS, Wilson JL, Binder W. Kappa-opioids as potential anti-inflammatory agents. Inflamm Res 1995;44 Suppl 3:231.
29. Walker JS, Wilson JL, Binder W, Scott C, Carmody JJ. The anti-inflammatory effects of opioids: Their possible relevance to the pathophysiology and treatment of rheumatoid arthritis. Rheum Arth ID Res Alert 1997;1:291-9.